Pfizer to hire more than 450 workers at Terre Haute inhalable insulin plant
TERRE HAUTE -- Pfizer Inc., the world's largest drugmaker, plans to hire more than 450 workers and invest $170 million at a western Indiana plant where it manufactures the nation's first inhalable version of insulin. Pfizer said Wednesday it will hire the workers over the next two to three years, boosting to about 650 the number of employees at its Exubera inhaler production line. It also plans to invest $170 million at the 120,000-square-foot Terre Haute plant by 2009. New York-based Pfizer received federal approval in late January to market the Exubera inhaler for controlling Type 1 and Type 2 diabetes in adults. The device offers the first new way of delivering insulin since the discovery of the hormone in the 1920s.

